Ontology type: schema:ScholarlyArticle
2021-08-05
AUTHORSSterling A. Wheaten, Jiandong Zhang, George A. Stouffer
ABSTRACTPurpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility. More... »
PAGES19
http://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8
DOIhttp://dx.doi.org/10.1007/s12170-021-00682-8
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1140215697
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.410711.2",
"name": [
"Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "Wheaten",
"givenName": "Sterling A.",
"id": "sg:person.0707674473.57",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707674473.57"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.410711.2",
"name": [
"Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "Zhang",
"givenName": "Jiandong",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA",
"id": "http://www.grid.ac/institutes/grid.410711.2",
"name": [
"Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA"
],
"type": "Organization"
},
"familyName": "Stouffer",
"givenName": "George A.",
"id": "sg:person.01135215515.04",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135215515.04"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00392-020-01595-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1124679982",
"https://doi.org/10.1007/s00392-020-01595-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-08-05",
"datePublishedReg": "2021-08-05",
"description": "Purpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility.",
"genre": "article",
"id": "sg:pub.10.1007/s12170-021-00682-8",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1039476",
"issn": [
"1932-9520",
"1932-9563"
],
"name": "Current Cardiovascular Risk Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "10",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "15"
}
],
"keywords": [
"catheter-based renal denervation",
"renal denervation",
"treatment of hypertension",
"blood pressure",
"clinical trials",
"new catheter",
"Symplicity HTN-3 trial",
"effect of RDN",
"lower blood pressure",
"sham-controlled study",
"current treatment strategies",
"early clinical trials",
"poor clinical trial design",
"clinical trial design",
"improved study design",
"failure of concept",
"renal nerves",
"resistant hypertension",
"therapeutic failure",
"treatment strategies",
"retrospective analysis",
"hypertension",
"clinical role",
"catheter technology",
"trial design",
"concept trial",
"control group",
"ReviewThe use",
"Recent FindingsIn",
"SummaryRecent developments",
"study design",
"procedural techniques",
"catheter",
"trials",
"denervation",
"patients",
"significant reduction",
"consistent reduction",
"consistent evidence",
"Recent studies",
"treatment",
"consistent ablation",
"failure",
"nerve",
"study",
"FindingsIn",
"pressure",
"ablation",
"procedure-based approach",
"future research",
"reduction",
"early proof",
"contemporary studies",
"group",
"evidence",
"reevaluation",
"recommendations",
"development",
"role",
"update",
"effect",
"utility",
"changes",
"use",
"promise",
"purpose",
"strategies",
"analysis",
"credence",
"efforts",
"research",
"technique",
"design",
"interest",
"approach",
"fundamental principles",
"proof",
"first generation technology",
"field",
"principles",
"aftermath",
"technology",
"concept",
"notion"
],
"name": "An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension",
"pagination": "19",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1140215697"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12170-021-00682-8"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12170-021-00682-8",
"https://app.dimensions.ai/details/publication/pub.1140215697"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:31",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_904.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12170-021-00682-8"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00682-8'
This table displays all metadata directly associated to this object as RDF triples.
159 TRIPLES
22 PREDICATES
110 URIs
101 LITERALS
6 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s12170-021-00682-8 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1102 |
3 | ″ | schema:author | N9d81390c113e4ab8aca981e0b78c181b |
4 | ″ | schema:citation | sg:pub.10.1007/s00392-020-01595-z |
5 | ″ | schema:datePublished | 2021-08-05 |
6 | ″ | schema:datePublishedReg | 2021-08-05 |
7 | ″ | schema:description | Purpose of ReviewThe use of catheter-based renal denervation (RD) for the treatment of hypertension showed promise in early proof-of-concept trials; however, enthusiasm to pursue clinical trials outpaced efforts to understand underlying fundamental principles. The Symplicity HTN-3 trial was a randomized, sham-controlled study that found that the effect of RD on blood pressure in patients with resistant hypertension was no different than seen in the control group. Retrospective analyses showed that the therapeutic failure more likely resulted from suboptimal first-generation technology and poor clinical trial design rather than a failure of concept. This led to the development of new catheters which deliver a more consistent ablation to renal nerves. The most recent studies which utilize these new catheters have demonstrated a consistent reduction in blood pressure, and interest in the field has been renewed.Recent FindingsIn the aftermath of early clinical trials, a reevaluation of the field of RD resulted in recommendations for improved study design, enhanced procedural techniques, and newly developed catheter technologies. These changes have been incorporated into contemporary studies, which have provided consistent evidence that catheter-based RD can cause a significant reduction in blood pressure in patients with hypertension.SummaryRecent developments in the field of RD have lent credence to the notion that a procedure-based approach to lower blood pressure may augment current treatment strategies for hypertension. Future research will help to better define its clinical role and utility. |
8 | ″ | schema:genre | article |
9 | ″ | schema:inLanguage | en |
10 | ″ | schema:isAccessibleForFree | false |
11 | ″ | schema:isPartOf | N8c060b90ac6342cca00090a4c583899e |
12 | ″ | ″ | N93f09b921a414808b1311b38e8b9f606 |
13 | ″ | ″ | sg:journal.1039476 |
14 | ″ | schema:keywords | FindingsIn |
15 | ″ | ″ | Recent FindingsIn |
16 | ″ | ″ | Recent studies |
17 | ″ | ″ | ReviewThe use |
18 | ″ | ″ | SummaryRecent developments |
19 | ″ | ″ | Symplicity HTN-3 trial |
20 | ″ | ″ | ablation |
21 | ″ | ″ | aftermath |
22 | ″ | ″ | analysis |
23 | ″ | ″ | approach |
24 | ″ | ″ | blood pressure |
25 | ″ | ″ | catheter |
26 | ″ | ″ | catheter technology |
27 | ″ | ″ | catheter-based renal denervation |
28 | ″ | ″ | changes |
29 | ″ | ″ | clinical role |
30 | ″ | ″ | clinical trial design |
31 | ″ | ″ | clinical trials |
32 | ″ | ″ | concept |
33 | ″ | ″ | concept trial |
34 | ″ | ″ | consistent ablation |
35 | ″ | ″ | consistent evidence |
36 | ″ | ″ | consistent reduction |
37 | ″ | ″ | contemporary studies |
38 | ″ | ″ | control group |
39 | ″ | ″ | credence |
40 | ″ | ″ | current treatment strategies |
41 | ″ | ″ | denervation |
42 | ″ | ″ | design |
43 | ″ | ″ | development |
44 | ″ | ″ | early clinical trials |
45 | ″ | ″ | early proof |
46 | ″ | ″ | effect |
47 | ″ | ″ | effect of RDN |
48 | ″ | ″ | efforts |
49 | ″ | ″ | evidence |
50 | ″ | ″ | failure |
51 | ″ | ″ | failure of concept |
52 | ″ | ″ | field |
53 | ″ | ″ | first generation technology |
54 | ″ | ″ | fundamental principles |
55 | ″ | ″ | future research |
56 | ″ | ″ | group |
57 | ″ | ″ | hypertension |
58 | ″ | ″ | improved study design |
59 | ″ | ″ | interest |
60 | ″ | ″ | lower blood pressure |
61 | ″ | ″ | nerve |
62 | ″ | ″ | new catheter |
63 | ″ | ″ | notion |
64 | ″ | ″ | patients |
65 | ″ | ″ | poor clinical trial design |
66 | ″ | ″ | pressure |
67 | ″ | ″ | principles |
68 | ″ | ″ | procedural techniques |
69 | ″ | ″ | procedure-based approach |
70 | ″ | ″ | promise |
71 | ″ | ″ | proof |
72 | ″ | ″ | purpose |
73 | ″ | ″ | recommendations |
74 | ″ | ″ | reduction |
75 | ″ | ″ | reevaluation |
76 | ″ | ″ | renal denervation |
77 | ″ | ″ | renal nerves |
78 | ″ | ″ | research |
79 | ″ | ″ | resistant hypertension |
80 | ″ | ″ | retrospective analysis |
81 | ″ | ″ | role |
82 | ″ | ″ | sham-controlled study |
83 | ″ | ″ | significant reduction |
84 | ″ | ″ | strategies |
85 | ″ | ″ | study |
86 | ″ | ″ | study design |
87 | ″ | ″ | technique |
88 | ″ | ″ | technology |
89 | ″ | ″ | therapeutic failure |
90 | ″ | ″ | treatment |
91 | ″ | ″ | treatment of hypertension |
92 | ″ | ″ | treatment strategies |
93 | ″ | ″ | trial design |
94 | ″ | ″ | trials |
95 | ″ | ″ | update |
96 | ″ | ″ | use |
97 | ″ | ″ | utility |
98 | ″ | schema:name | An Update on Catheter-Based Renal Denervation for the Treatment of Hypertension |
99 | ″ | schema:pagination | 19 |
100 | ″ | schema:productId | N61238f38b7a84b4eb387cf5612f07b91 |
101 | ″ | ″ | Nc99b1483fc434757be0f67845e73407f |
102 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1140215697 |
103 | ″ | ″ | https://doi.org/10.1007/s12170-021-00682-8 |
104 | ″ | schema:sdDatePublished | 2022-05-10T10:31 |
105 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
106 | ″ | schema:sdPublisher | N22ab179812434e219939742110311454 |
107 | ″ | schema:url | https://doi.org/10.1007/s12170-021-00682-8 |
108 | ″ | sgo:license | sg:explorer/license/ |
109 | ″ | sgo:sdDataset | articles |
110 | ″ | rdf:type | schema:ScholarlyArticle |
111 | N22ab179812434e219939742110311454 | schema:name | Springer Nature - SN SciGraph project |
112 | ″ | rdf:type | schema:Organization |
113 | N2fa44eb2032a48c683ab41dd0671d9f1 | schema:affiliation | grid-institutes:grid.410711.2 |
114 | ″ | schema:familyName | Zhang |
115 | ″ | schema:givenName | Jiandong |
116 | ″ | rdf:type | schema:Person |
117 | N37c3d23f6d30470a907fbe474b542581 | rdf:first | sg:person.01135215515.04 |
118 | ″ | rdf:rest | rdf:nil |
119 | N5a346ce4ce844f5bb617d3add88df2ab | rdf:first | N2fa44eb2032a48c683ab41dd0671d9f1 |
120 | ″ | rdf:rest | N37c3d23f6d30470a907fbe474b542581 |
121 | N61238f38b7a84b4eb387cf5612f07b91 | schema:name | dimensions_id |
122 | ″ | schema:value | pub.1140215697 |
123 | ″ | rdf:type | schema:PropertyValue |
124 | N8c060b90ac6342cca00090a4c583899e | schema:issueNumber | 10 |
125 | ″ | rdf:type | schema:PublicationIssue |
126 | N93f09b921a414808b1311b38e8b9f606 | schema:volumeNumber | 15 |
127 | ″ | rdf:type | schema:PublicationVolume |
128 | N9d81390c113e4ab8aca981e0b78c181b | rdf:first | sg:person.0707674473.57 |
129 | ″ | rdf:rest | N5a346ce4ce844f5bb617d3add88df2ab |
130 | Nc99b1483fc434757be0f67845e73407f | schema:name | doi |
131 | ″ | schema:value | 10.1007/s12170-021-00682-8 |
132 | ″ | rdf:type | schema:PropertyValue |
133 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
134 | ″ | schema:name | Medical and Health Sciences |
135 | ″ | rdf:type | schema:DefinedTerm |
136 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
137 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | sg:journal.1039476 | schema:issn | 1932-9520 |
140 | ″ | ″ | 1932-9563 |
141 | ″ | schema:name | Current Cardiovascular Risk Reports |
142 | ″ | schema:publisher | Springer Nature |
143 | ″ | rdf:type | schema:Periodical |
144 | sg:person.01135215515.04 | schema:affiliation | grid-institutes:grid.410711.2 |
145 | ″ | schema:familyName | Stouffer |
146 | ″ | schema:givenName | George A. |
147 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01135215515.04 |
148 | ″ | rdf:type | schema:Person |
149 | sg:person.0707674473.57 | schema:affiliation | grid-institutes:grid.410711.2 |
150 | ″ | schema:familyName | Wheaten |
151 | ″ | schema:givenName | Sterling A. |
152 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707674473.57 |
153 | ″ | rdf:type | schema:Person |
154 | sg:pub.10.1007/s00392-020-01595-z | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1124679982 |
155 | ″ | ″ | https://doi.org/10.1007/s00392-020-01595-z |
156 | ″ | rdf:type | schema:CreativeWork |
157 | grid-institutes:grid.410711.2 | schema:alternateName | Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA |
158 | ″ | schema:name | Division of Cardiology and the McAllister Heart Institute, University of North Carolina, 27599-7075, Chapel Hill, NC, USA |
159 | ″ | rdf:type | schema:Organization |